The tumor suppressor p53 has an essential role in promoting antitumor drug response in its wild-type state, and tumor cells harboring wild-type p53 are generally recognized as being more sensitive to antitumor agents [42], which is consistent with the concept that activation of wild type p53 is sufficient to induce cell death [43]. Here, TP53 is linked to neoplasm.